# Agios (AGIO) — Overview

AGIO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/agio

## Price

Last close $32.32 on Oct 15, 2026. 52-week range $22.34 – $45.49.

## Company profile

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $98.3M |
| Revenue (quarter) | $44.7M |
| Revenue growth (year over year) | 259.25% |
| Gross profit (trailing twelve months) | $90.5M |
| Gross margin | 91.99% |
| Net income (trailing twelve months) | −$411.3M |
| Net income (quarter) | −$100.7M |
| Net income growth (year over year) | 10.10% |
| Net margin | -418.24% |
| Return on equity | -34.34% |
| EPS (trailing twelve months) | −$7.01 |
| Book value per share | $17.21 |
| P/E (trailing twelve months) | — |
| Price to book | 1.9 |
| Debt to assets | 7.43% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Agios (AGIO) profitable?

No. Agios reported a net loss of $411.3M over the trailing twelve months.

### How much revenue does Agios (AGIO) make?

Agios generated $98.3M in revenue over the trailing twelve months, up 259.25% year over year.

### How do I buy stock in Agios (AGIO)?

AGIO trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).